Get the Stockscreener App
7.06
1.00%
0.07
After Hours:
7.09
0.03
+0.42%
Lifecore Biomedical Inc stock is traded at $7.06, with a volume of 103.17K.
It is up +1.00% in the last 24 hours and down -10.63% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$6.99
Open:
$7.07
24h Volume:
103.17K
Relative Volume:
0.73
Market Cap:
$264.51M
Revenue:
$128.45M
Net Income/Loss:
$6.54M
P/E Ratio:
141.20
EPS:
0.05
Net Cash Flow:
$-8.79M
1W Performance:
-3.68%
1M Performance:
-10.63%
6M Performance:
-11.08%
1Y Performance:
+21.31%
1-Day Range:
$6.965
$7.21
1-Week Range:
$6.815
$7.39
52-Week Range:
$4.76
$8.9799
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.06 | 261.89M | 128.45M | 6.54M | -8.79M | 0.05 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.96 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.47 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-21-25 | Initiated | William Blair | Outperform |
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Stock (LFCR) Latest News
Lifecore to manufacture acne treatment batches for Indomo - Investing.com
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment - The Manila Times
Lifecore Biomedical signs new agreement with Indomo to support innovative drug/device combination acne treatment - marketscreener.com
Lifecore Biomedical Signs New Agreement with Indomo to - GlobeNewswire
2026-03-03 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical (LFCR) grants 30,000 RSUs to legal chief - Stock Titan
(LFCR) Volatility Zones as Tactical Triggers - Stock Traders Daily
Market Fear: Is Lifecore Biomedical Inc currently under institutional pressureSwing Trade & Smart Money Movement Tracker - baoquankhu1.vn
LFCR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
LFCR Should I Buy - Intellectia AI
LFCR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
2026-02-22 | Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
2026-02-19 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect | NDAQ:LFCR | Press Release - Stockhouse
Price-Driven Insight from (LFCR) for Rule-Based Strategy - Stock Traders Daily
Lifecore Biomedical (NASDAQ:LFCR) Shares Up 1.4%Should You Buy? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Lifecore Biomedical to Participate at DCAT Week 2026 - Bitget
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc. a top pick in the sectorJuly 2025 Retail & Free Verified High Yield Trade Plans - mfd.ru
Will Lifecore Biomedical Inc. (LDE) stock beat Nasdaq index returnsPrice Action & AI Based Buy and Sell Signals - mfd.ru
Can Lifecore Biomedical Inc. (LDE) stock sustain breakout momentum2025 Trade Ideas & Free Community Consensus Stock Picks - mfd.ru
Aug Reactions: Is Lifecore Biomedical Inc. in a bullish channelTrade Entry Report & Technical Entry and Exit Alerts - mfd.ru
2026-02-12 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Why Lifecore Biomedical Inc. stock remains on watchlists2025 Year in Review & Smart Investment Allocation Insights - mfd.ru
Quarterly Earnings: Will Lifecore Biomedical Inc. stock hit new highs in YEAR2025 Analyst Calls & Weekly Setup with High ROI Potential - mfd.ru
Does Lifecore Biomedical Inc. stock benefit from AI growthTrade Risk Assessment & Capital Efficiency Focused Strategies - mfd.ru
Will Lifecore Biomedical Inc. (LDE) stock see valuation expansionQuarterly Profit Review & Free Expert Verified Stock Movement Alerts - mfd.ru
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - ACCESS Newswire
(LFCR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Aug Reactions: What drives Lifecore Biomedical Incs stock priceMarket Volume Report & High Return Stock Watch Alerts - baoquankhu1.vn
Lifecore Biomedical (LFCR) Receives a Buy from Craig-Hallum - The Globe and Mail
2026-02-01 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Can Lifecore Biomedical Inc continue delivering strong returnsJuly 2025 Selloffs & Smart Allocation Stock Tips - baoquankhu1.vn
Market Recap: Is OPTT vulnerable to short sellersRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Portfolio Shifts: Is Lifecore Biomedical Inc a strong candidate for buy and holdIndex Update & Risk Controlled Swing Alerts - baoquankhu1.vn
Notice to Long-Term Shareholders of Lifecore Biomedical, - GlobeNewswire
Lifecore Biomedical Shareholders Seek Reforms After Securities Fraud Settlement - National Today
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
2026-01-29 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect | NDAQ:LFCR | Press Release - Stockhouse
Notice to Long-Term Shareholders of Ibotta, Inc. (NYSE: - GlobeNewswire
Is Lifecore Biomedical Inc. a defensive stockTrade Entry Summary & Free Community Supported Trade Ideas - mfd.ru
(LFCR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Lifecore Biomedical (NASDAQ:LFCR) Trading 2.8% HigherHere's Why - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - accessnewswire.com
2026-01-25 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Notice to Long-Term Shareholders of Ibatta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire
Aug PreEarnings: Is Lifecore Biomedical Inc trading at a discountJuly 2025 Decliners & Low Risk Entry Point Tips - baoquankhu1.vn
Notice to Long-Term Shareholders of CoreWeave, Inc. - GlobeNewswire
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
1.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):